X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Wockhardt Fact Sheet, Wockhardt Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Wockhardt Fact Sheet   (WOCK)

Here is the latest financial fact sheet of Wockhardt. For more details, see the Wockhardt quarterly results and Wockhardt share price and chart. For a sector overview, read our pharmaceuticals sector report.

WOCKHARDT LTD. Price History

Price Rs 599.0
Mkt Cap Rs m 65,914
Vol '000 33.5
P/E X -9.9
P/CF X -85.5
EPS (TTM) Rs -60.5
% ch % 0.8
No. of shares m 110.04
% ch week % -6.6
% ch 1-mth % -16.8
% ch 12-mth % -3.1
52 week H/L Rs 1,012.0/531.5
(As on Jul 18, 2018 10:31:00 AM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

WOCKHARDT LTD. Financials

No. of Mths
Year Ending
12
Mar-13
*
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
5-Yr Chart
Click to enlarge
WOCKHARDT LTD. EQUITY SHARE DATA
High Rs2,1662,0701,9802,0001,129 
Low Rs598337455706627 
Sales per share (Unadj.) Rs511.9440.1407.2403.0363.1 
Earnings per share (Unadj.) Rs145.576.636.822.8-20.4 
Diluted earnings per shareRs144.976.436.822.9-20.5 
Cash flow per share (Unadj.) Rs156.689.450.035.7-7.0 
Dividends per share (Unadj.) Rs5.0010.0020.00010.00 
Adj. dividends per shareRs4.989.9720.010.0010.05 
Dividend yield (eoy) %0.40.81.601.1 
Book value per share (Unadj.) Rs219.5299.1335.1341.6301.8 
Adj. book value per shareRs218.6298.3335.2343.1303.2 
Shares outstanding (eoy) m109.58109.75110.07110.51110.55 
Bonus/Rights/Conversions  ESOPESOPESOP-IS 
Price / Sales ratio x2.72.73.03.42.4 
Avg P/E ratio x9.515.733.159.3-42.9 
P/CF ratio (eoy) x8.813.524.337.9-125.9 
Price / Book Value ratio x6.34.03.64.02.9 
Dividend payout %3.413.154.40-48.9 
Avg Mkt Cap Rs m151,429132,062133,983149,50997,063 
No. of employees `000NA8.66.87.46.8 
Total wages/salary Rs m6,5597,6868,6899,5089,665 
Avg. sales/employee Rs ThNM5,616.76,557.76,037.25,931.8 
Avg. wages/employee Rs ThNM893.81,271.41,289.01,428.1 
Avg. net profit/employee Rs ThNM977.6592.5342.0-334.0 
WOCKHARDT LTD. INCOME DATA
Net Sales Rs m56,09448,30444,81544,53040,146 
Other income Rs m5123846666611,143 
Total revenues Rs m56,60648,68845,48145,19141,289 
Gross profit Rs m20,62510,2577,0944,942128 
Depreciation Rs m1,2211,3991,4541,4191,489 
Interest Rs m2,1548345521,2902,253 
Profit before tax Rs m17,7628,4085,7532,895-2,472 
Minority Interest Rs m0-21-7860 
Prior Period Items Rs m-60000 
Extraordinary Inc (Exp) Rs m767498000 
Tax Rs m2,5824791,627379-211 
Profit after tax Rs m15,9418,4074,0492,522-2,260 
Gross profit margin %36.821.215.811.10.3 
Effective tax rate %14.55.728.313.18.5 
Net profit margin %28.417.49.05.7-5.6 
WOCKHARDT LTD. BALANCE SHEET DATA
Current assets Rs m33,26933,55934,63739,51946,160 
Current liabilities Rs m17,73517,43217,75218,41919,258 
Net working cap to sales %27.733.437.747.467.0 
Current ratio x1.91.92.02.12.4 
Inventory Days Days69758390101 
Debtors Days Days6236539194 
Net fixed assets Rs m24,80530,02233,90937,36940,165 
Share capital Rs m548549550553553 
"Free" reserves Rs m21,53128,21936,33237,19932,814 
Net worth Rs m24,05632,82936,88337,75133,367 
Long term debt Rs m14,75211,02314,27019,20631,903 
Total assets Rs m60,22766,22071,71581,20989,687 
Interest coverage x9.211.111.43.2-0.1 
Debt to equity ratio x0.60.30.40.51.0 
Sales to assets ratio x0.90.70.60.50.4 
Return on assets %30.014.06.44.70 
Return on equity %66.325.611.06.7-6.8 
Return on capital %53.322.212.27.4-0.3 
Exports to sales %20.912.810.011.60 
Imports to sales %5.17.86.24.50 
Exports (fob) Rs m11,7406,1804,4715,1770 
Imports (cif) Rs m2,8433,7602,7731,9900 
Fx inflow Rs m14,58211,02610,7407,5899,121 
Fx outflow Rs m3,6244,3613,3562,8782,133 
Net fx Rs m10,9596,6657,3834,7116,988 
WOCKHARDT LTD. CASH FLOW
From Operations Rs m 15,324 14,763 3,550 716 -2,695 
From Investments Rs m 10,854 -8,516 -2,066 -8,182 -6,863 
From Financial Activity Rs m -22,458 -6,013 -757 2,543 12,545 
Net Cashflow Rs m 3,720 234 727 -4,941 3,010 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 74.5%
Foreign collaborators 0.0%
Indian inst/Mut Fund 2.3%
FIIs 7.7%
ADR/GDR 0.1%
Free float 15.4%
Shareholders 67,757
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Wockhardt Towers, C/2-G Block, BKC, Bandra (E), Mumbai-400 051
E-MAIL investorrelations@wockhardt.com WEB www.wockhardt.com
TELEPHONE (022) 2653 4444 FAX (022) 2652 3905
SECTOR PHARMACEUTICALS GROUP KHORAKIWALA
TR AGENT Link Intime India, C13, Pannalal Silk Mills Cmpd., LBS Marg, Mumbai-78
AUDITOR Haribhakti & Co.
CHM: Habil Khorakiwala COMP SEC: V. R. Khetan YEAR OF INC: 1973 BSE CODE: 532300 FV (Rs): 5 DIV YIELD (%): 1.7

More Pharmaceuticals Company Fact Sheets:   SUN PHARMA  PLETHICO PHARMA  IPCA LABS  UNICHEM LAB  PFIZER  

Compare WOCKHARDT LTD. With:   SUN PHARMA  PLETHICO PHARMA  IPCA LABS  UNICHEM LAB  PFIZER  

Compare WOCKHARDT LTD. With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex at All-Time High; Energy & IT Stocks Top Gainers(09:30 am)

Asian stock markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 1% while the Hang Seng is up 0.3%.

Views on news

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

How to Avoid a 90% Loss Suffered by This Super Investor(The 5 Minute Wrapup)

Jul 12, 2018

Blindly following super investors is a dangerous game to play. Here's how you can avoid such mistakes.

The Answer to Your Wealth Worries: Small Caps (Especially Now)(Profit Hunter)

Jul 10, 2018

If you're worried about the markets - you are on the wrong track. This is opportunity - put your wealth-building hat on, instead - Richa shows you how...

The Multiple Problems with the Minimum Support Price (MSP) System(Vivek Kaul's Diary)

Jul 11, 2018

The price signals that MSP sends out, creates its own set of problems.

New Fund Offer - ICICI Prudential Pharma Healthcare and Diagnostics Fund - Should You Invest?(Outside View)

Jul 6, 2018

ICICI AMC launches an open -ended equity fund following Pharma, Healthcare, Diagnostic and allied theme.

When Disappointment Panda is Around. Buy Quality Stock like This!(Chart Of The Day)

Jul 6, 2018

Buy Companies that can fight all kinds of Pandas and Bears in the long run.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. 8-QTR ANALYSIS

COMPARE WOCKHARDT LTD. WITH

MARKET STATS